These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38771784)

  • 1. Mixed methods approach to examining the implementation experience of a phone-based survey for a SARS-CoV-2 test-negative case-control study in California.
    Fukui N; Li SS; DeGuzman J; Myers JF; Openshaw J; Sharma A; Watt J; Lewnard JA; Jain S; Andrejko KL; Pry JM;
    PLoS One; 2024; 19(5):e0301070. PubMed ID: 38771784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing SARS-CoV-2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022.
    Woelk G; Maphosa T; Machekano R; Chauma-Mwale A; Makonokaya L; Zimba SB; Chamanga RK; Nyirenda R; Auld A; Kim E; Sampathkumar V; Ahimbisibwe A; Kalitera L; Kim L; Maida A
    BMJ Glob Health; 2024 May; 9(5):. PubMed ID: 38754899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection - California, February-December 2021.
    Andrejko KL; Pry JM; Myers JF; Fukui N; DeGuzman JL; Openshaw J; Watt JP; Lewnard JA; Jain S;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):212-216. PubMed ID: 35143470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study.
    Sundaram ME; Calzavara A; Mishra S; Kustra R; Chan AK; Hamilton MA; Djebli M; Rosella LC; Watson T; Chen H; Chen B; Baral SD; Kwong JC
    CMAJ; 2021 May; 193(20):E723-E734. PubMed ID: 33906966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons Learned From a Sequential Mixed-Mode Survey Design to Recruit and Collect Data From Case-Control Study Participants: Formative Evaluation.
    Tran AD; White AE; Torok MR; Jervis RH; Albanese BA; Scallan Walter EJ
    JMIR Form Res; 2024 May; 8():e56218. PubMed ID: 38801768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
    Adorni F; Prinelli F; Bianchi F; Giacomelli A; Pagani G; Bernacchia D; Rusconi S; Maggi S; Trevisan C; Noale M; Molinaro S; Bastiani L; Fortunato L; Jesuthasan N; Sojic A; Pettenati C; Tavio M; Andreoni M; Mastroianni C; Antonelli Incalzi R; Galli M
    JMIR Public Health Surveill; 2020 Sep; 6(3):e21866. PubMed ID: 32650305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19.
    Geldsetzer P
    J Med Internet Res; 2020 Apr; 22(4):e18790. PubMed ID: 32240094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the Front (Phone) Lines: Results of a COVID-19 Hotline.
    Margolius D; Hennekes M; Yao J; Einstadter D; Gunzler D; Chehade N; Sehgal AR; Tarabichi Y; Perzynski AT
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S95-S102. PubMed ID: 33622824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing participants who respond to text, email, phone calls, or postcards in a SARS-CoV-2 prevalence study.
    Duszynski TJ; Fadel W; Dixon B; Yiannoutsos CT; Halverson P; Menachemi N
    BMC Public Health; 2024 Apr; 24(1):1113. PubMed ID: 38649843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences, Attitudes, and Needs of Users of a Pregnancy and Parenting App (Baby Buddy) During the COVID-19 Pandemic: Mixed Methods Study.
    Rhodes A; Kheireddine S; Smith AD
    JMIR Mhealth Uhealth; 2020 Dec; 8(12):e23157. PubMed ID: 33264100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System.
    Baker JM; Nelson KN; Overton E; Lopman BA; Lash TL; Photakis M; Jacob JT; Roback JD; Fridkin SK; Steinberg JP
    Ann Intern Med; 2021 May; 174(5):649-654. PubMed ID: 33513035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
    Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
    Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Knowledge of and Behavior Toward COVID-19 and the Possibility of Isolating at a City Level: Survey Study.
    Verot E; Chaux R; Gagnaire J; Bonjean P; Gagneux-Brunon A; Berthelot P; Pelissier C; Boulamail B; Chauvin F; Pozzetto B; Botelho-Nevers E
    JMIR Public Health Surveill; 2024 Apr; 10():e47170. PubMed ID: 38602767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Testing, Positivity Rates, and Healthcare Outcomes in a Cohort of 22,481 Breast Cancer Survivors.
    Haque R; Chen L
    JCO Clin Cancer Inform; 2021 Feb; 5():168-175. PubMed ID: 33539175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.